Tango Therapeutics TNGX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's cash ratio?
- Tango Therapeutics (TNGX) reported cash ratio of 11.2× in Q1 2026.
- How has Tango Therapeutics's cash ratio changed year-over-year?
- Tango Therapeutics's cash ratio increased by 557.3% year-over-year, from 1.7× to 11.2×.
- What is the long-term trend for Tango Therapeutics's cash ratio?
- Over 5 years (2020 to 2025), Tango Therapeutics's cash ratio has grown at a 176.9% compound annual growth rate (CAGR), from 0× to 5.2×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.